Archive
Max Reinhardt – The role of industry in advancing spinal surgical care
Max Reinhardt – The role of industry in advancing spinal surgical care Max Reinhardt, Worldwide President at DePuy Synthes Spine, speaks about the future outlook for spinal implant companies at
IDD Therapy: Evolving conservative spinal treatment modalities
John Wood, MCSP looks at the physiological effects of IDD Therapy spinal decompression on connective tissues As part of conservative care, IDD Therapy® spinal decompression is emerging as an invaluable
Single-level anterior cervical discectomy and fusion
Does anterior plating increase fusion rates? Abstract Introduction Anterior plating provides a rigid construct and improves fusion rates in cases of multi-level cervical degenerative disease. However, there still remains a
Introducing Ranier’s unique polymer cervical fusion cage
Anatom-C™ is a single-piece unique polymer fusion cage device intended to restore intradiscal height and sagittal contour for diseased and/or degenerate intervertebral discs in the cervical spine (C3–C7) of patients requiring surgical
OXIPLEX® Adhesion-Barrier
Ever since surgical discectomy procedures have been performed on the spine, whether involving laminectomy or laminotomy, surgeons have had to learn to deal with the consequence of the scarring process:
InFill® graft delivery system by Pinnacle Spine Group
When it comes to spine surgery, Pinnacle Spine believes in creating better outcomes for patients, surgeons and hospitals. That’s why we developed the patented InFill® Graft Delivery System designed to
Ann Glover
Ann Glover, Founder and Chair Trustee of Cauda Equina Syndrome (CES) UK Charity Q What is your position in Cauda Equina Syndrome UK Charity and what does your role entail?
Surgery in the womb to be improved by research into new tools and imaging techniques
Surgeons will be able to use better tools, imaging techniques and therapies in future operations on unborn babies due to a £10 million award from the Wellcome Trust and the
Managing SI joint conditions
SI-BONE, Inc. is the leading medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to SI joint disorders.
New medical research set to benefit half of UK cystic fibrosis population
New advances in cystic fibrosis medical research announced in June have been welcomed by the Cystic Fibrosis Trust as it stands to benefit up to half of all people living
